Table 2 Candidate Genes from Microarray.

From: A Whole Blood Molecular Signature for Acute Myocardial Infarction

Gene

 

Coefficient

Discovery

Validation

Fold-Change

p-value

adjusted p-value

Fold-Change

p-value

adjusted p-value

HBEGF

heparin-binding EGF-like growth factor

0.1132

5.40

7.40E–10

<0.0005

5.16

1.6E–06

<0.0005

SYTL3

synaptotagmin–like 3

0.0991

3.74

7.59E–08

<0.0005

2.17

1.1E–02

0.088

EDN1

endothelin 1

0.0896

3.18

1.24E–07

<0.0005

1.47

1.1E–01

0.295

NR4A2

nuclear receptor subfamily 4, group A, member 2

0.0583

5.80

4.24E–08

<0.0005

11.57

2.2E–12

<0.0005

NFKBIA

NF–Kappa–B inhibitor alpha

0.0563

3.55

2.05E–07

<0.0005

5.41

1.4E–10

<0.0005

VPS8

vacuolar protein sorting 8 homolog

0.0555

3.08

3.14E–07

<0.005

1.80

2.9E–02

0.140

NR4A3

nuclear receptor subfamily 4, group A, member 3

0.0461

8.39

3.36E–08

<0.0005

6.04

1.2E–07

<0.0005

SULF1

sulfatase 1

0.0283

8.89

1.97E–06

<0.005

2.74

1.9E–03

<0.05

RNASE1

ribonuclease, RNase A family, 1

0.0119

4.45

3.29E–06

<0.005

2.08

6.9E–05

<0.05

CCL20

chemokine (C–C motif) ligand 20

0.0014

6.23

3.65E–06

<0.005

8.45

1.8E–10

<0.0005

MGP

matrix Gla protein

0.0013

7.86

5.16E–06

<0.005

5.83

9.6E–09

<0.0005

  1. Individual genes from enriched CEC microarray used in the 11-gene model to discriminate AMI from control.